Duplication within chromosome 17p11.2 in 12 families of French ancestry with Charcot-Marie-Tooth disease type 1a. The French CMT Research Group.

A Brice, N Ravise, G Stevanin, M Gugenheim, P Bouche, C Penet, Y Agid
Journal of Medical Genetics. 1992-11-01; 29(11): 807-812
DOI: 10.1136/jmg.29.11.807

PubMed
Lire sur PubMed



1. J Med Genet. 1992 Nov;29(11):807-12.

Duplication within chromosome 17p11.2 in 12 families of French ancestry with
Charcot-Marie-Tooth disease type 1a. The French CMT Research Group.

Brice A(1), Ravisé N, Stevanin G, Gugenheim M, Bouche P, Penet C, Agid Y.

Author information:
(1)INSERM U289, Hôpital de la Salpêtrière, Paris, France.

Hereditary motor and sensory neuropathy type I (HMSN I), also designated
Charcot-Marie-Tooth disease type 1 (CMT1), is a peripheral neuropathy frequently
inherited as an autosomal dominant trait, characterised by progressive distal
muscular atrophy and sensory loss with markedly decreased nerve conduction
velocity. A duplication within chromosome 17p11.2, cosegregating with the
disease, has recently been reported in several CMT1a families. In order to
estimate the frequency of this anomaly and determine the location of a
duplication in this region, 12 CMT1 families were analysed with polymorphic DNA
markers located within 17p11.2-12. Duplications were found in all families
including loci D17S61 (EW401), D17S122 (VAW409R3a and RM11-GT), and D17S125
(VAW412R3). The duplications were completely linked and associated with the
disease (lod score of 20.77 at zero recombination). Screening for the RM11-GT
microsatellite showed that most of the duplicated haplotypes were heterozygous,
supporting the hypothesis that the duplication resulted from an unequal crossing
over. There was no significant haplotype association within the duplicated region
suggesting that the duplication resulted de novo as an independent event in each
family. In one family, recombination within the duplicated region was observed,
indicating that genetic instability in 17p11.2 might be related to a high
recombination rate. Since most cases of CMT1a seem to result from this segmental
trisomy, it can be used as a basis for DNA diagnosis of the disease.

DOI: 10.1136/jmg.29.11.807
PMCID: PMC1016177
PMID: 1453432 [Indexed for MEDLINE]

Auteurs Bordeaux Neurocampus